Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Aug 6, 2025 | O’Keefe Stevens Advisory, Inc | - | - | 3133.T, 3201.T, 6249.T, 7952.T, 8291.T, 9312.T, CPH.TO, FILA.MI, LNF.TO, NLOP | Japan, liquidation, real estate, small cap, Specialty Pharma, value | Japan offers compelling value opportunities with companies trading at significant discounts to book value while maintaining profitability. Corporate reforms underway over the past 2 years are helping unlock value, and many companies provide downside protection through excess cash or undervalued real estate. The manager has identified approximately 400 Japanese equities on his watchlist, with many trading under book value. | View | |
| 2025 Q2 | Jul 22, 2025 | Curreen Capital | 14.1% | 8.7% | 3133.T, 3201.T, 6249.T, 7952.T, 8291.T, 9312.T, CPH.TO, FILA.MI, LNF.TO, NLOP | Japan, liquidation, real estate, small cap, Specialty Pharma, value | Japan offers compelling value opportunities with companies trading at significant discounts to book value, often with substantial cash positions and real estate holdings. Corporate reforms over the past two years are helping unlock value, and many companies pay dividends while investors wait for market recognition. | VFC ENR GR GETB LN FTDR FTRE CACC AAP |
View |
| 2025 Q2 | Jul 11, 2025 | HalvioCapital | 6.7% | - | 3133.T, 3201.T, 6249.T, 7952.T, 8291.T, 9312.T, CPH.TO, FILA.MI, LNF.TO, NLOP | Japan, REITs, small caps, Specialty Pharma, spinoffs, value | Japan offers compelling value opportunities with companies trading at significant discounts to book value, often with diverse business segments and strong cash positions. Corporate reforms underway over the past 2 years are helping unlock value, while companies maintain profitability and pay dividends during the value realization period. | NLOP CPH CN 6249 JP 7952 JP 8291 JP |
View |
| 2025 Q2 | Jun 30, 2025 | Distillate Capital Large Cap Value | - | 1.9% | 3133.T, 3201.T, 6249.T, 7952.T, 8291.T, 9312.T, CPH.TO, FILA.MI, LNF.TO, NLOP | Japan, liquidation, real estate, REIT, small cap, Specialty Pharma, spinoffs, value | Japan offers compelling value opportunities with companies trading at significant discounts to book value, often with substantial cash positions and real estate holdings. Corporate reforms over the past two years are helping unlock value, and many companies pay dividends while investors wait for market recognition. | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||